Skip to main content
Article thumbnail
Location of Repository

Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells

By Haiyan Liu, Xianrang Song, Chunxi Liu, Li Xie, Ling Wei and Ruopeng Sun
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2008). Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res
  2. (1992). AW: Toxicity of singleday high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma.
  3. (1999). Badal MD: Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.
  4. (1999). Castleberry RP: The International Neuroblastoma Pathology Classification (the Shimada system). Cancer
  5. (2007). Dahiya R: Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene
  6. (2006). Fisher PB: Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res
  7. (2006). Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol
  8. (1997). Ling V: MYCN protein expression as a predictor of neuroblastoma prognosis. Clin Cancer Res
  9. (2006). PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA
  10. (2008). PB: Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene
  11. (2005). PB: Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene
  12. (2002). PB: Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene
  13. (1999). Predicting outcome in neuroblastoma.
  14. (1997). The International Neuroblastoma Risk Groups (INRG): a preliminary report.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.